These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 31118933)

  • 1. Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation.
    Chen C; Wei YZ; He XM; Li DD; Wang GQ; Li JJ; Zhang F
    Front Immunol; 2019; 10():936. PubMed ID: 31118933
    [No Abstract]   [Full Text] [Related]  

  • 2. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia.
    He XM; Zhou YZ; Sheng S; Li JJ; Wang GQ; Zhang F
    Oxid Med Cell Longev; 2020; 2020():2963540. PubMed ID: 33294118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
    Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
    J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
    Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q
    Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroquercetin alleviates dopamine neuron loss via regulating TREM2 activation.
    Yang R; Li DD; Li XX; Yang XX; Gao HM; Zhang F
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):132179. PubMed ID: 38723817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
    Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
    Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720 Inhibits MPP
    Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual modulation on glial cells by tetrahydroxystilbene glucoside protects against dopamine neuronal loss.
    Zhou Y; Wang G; Li D; Wang Y; Wu Q; Shi J; Zhang F
    J Neuroinflammation; 2018 May; 15(1):161. PubMed ID: 29801454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model.
    Qiu J; Chen Y; Zhuo J; Zhang L; Liu J; Wang B; Sun D; Yu S; Lou H
    Neuropharmacology; 2022 Apr; 207():108963. PubMed ID: 35065082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
    Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
    Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease.
    Ahmad MH; Fatima M; Ali M; Rizvi MA; Mondal AC
    Neuropharmacology; 2021 Dec; 201():108831. PubMed ID: 34655599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1/Parkin pathway.
    Wang A; Zhong G; Ying M; Fang Z; Chen Y; Wang H; Wang C; Liu C; Guo Y
    Neuropharmacology; 2024 Oct; 257():110063. PubMed ID: 38972372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
    Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y
    Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity.
    Huang C; Lin F; Wang G; Lu D; Wu Q; Liu J; Shi J; Zhang F
    Oxid Med Cell Longev; 2018; 2018():7927568. PubMed ID: 29576855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.
    Zhang F; Shi JS; Zhou H; Wilson B; Hong JS; Gao HM
    Mol Pharmacol; 2010 Sep; 78(3):466-77. PubMed ID: 20554604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.
    Qiao C; Zhang Q; Jiang Q; Zhang T; Chen M; Fan Y; Ding J; Lu M; Hu G
    J Neuroinflammation; 2018 Jul; 15(1):193. PubMed ID: 29966531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson's disease model.
    Qiu X; Wang Q; Hou L; Zhang C; Wang Q; Zhao X
    Toxicol Lett; 2021 Oct; 349():1-11. PubMed ID: 34052309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.